首页 | 本学科首页   官方微博 | 高级检索  
     


Early B cells repopulation in multiple sclerosis patients treated with rituximab is not predictive of a risk of relapse or clinical progression
Authors:Dorcet  Guillaume  Migné   Hugo  Biotti   Damien  Bost   Chloé  Lerebours  Fleur  Ciron  Jonathan  Treiner  Emmanuel
Affiliation:1.Department of Neurology, CRC-SEP, University Hospital of Toulouse, Toulouse, France
;2.INSERM U1291–CNRS 5051, INFINITy, Toulouse, France
;3.Immunology Laboratory, Biology Department, University Hospital of Toulouse, Toulouse, France
;
Abstract:Journal of Neurology - It is currently unknown whether early B cell reconstitution (EBR) in MS patients under rituximab is associated with a risk of relapse or progression. Analyzing EBR in...
Keywords:
本文献已被 SpringerLink 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号